Drug Trial Radar · NCT06416410
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation
Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
392
Planned (sponsor's estimate)
Start
Aug 7, 2024
Primary completion
Sep 30, 2029
Study completion Aug 2030
Sponsor
- Lead sponsor
- Allist Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3 study will evaluate the efficacy of JAB-21822+JAB-3312 versus tislelizumab (PD-1 Ab) combined with pemetrexed+carboplatin as the first line treatment in subjects with KRAS G12C mutated locally advanced or metastatic non-small cell lung cancer (NSCLC).
Conditions
- Advanced Non-squamous Non-small-cell Lung Cancer
- Metastatic Non-squamous Non Small Cell Lung Cancer
Interventions
JAB-21822Drug
JAB-21822 administered orally as a tablet
TislelizumabDrug
Tislelizumab administered as an intravenous (IV) infusion
JAB-3312Drug
JAB-3312 administered orally as a tablet or capsule
PemetrexedDrug
Pemetrexed administered as an intravenous (IV) infusion
CarboplatinDrug
Carboplatin administered as an intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Outcome Progression-free Survival (PFS)Time frame: From Baseline up to 4 years
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
Anhui Province cancer hospital
Hefei, Anhui, China · Not yet recruiting
Pecking Union Medical College Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Cancer Hospital Chinese Academy Of Medical Sciences
Beijing, Beijing Municipality, China · Recruiting
Beijing Tiantan Hospital, Captal Medical University
Beijing, Beijing Municipality, China · Not yet recruiting
Beijing Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University Third Hospital
Beijing, Beijing Municipality, China · Recruiting
Beijing Chest Hospital ,Capital Medical University
Beijing, Beijing Municipality, China · Recruiting
Fujian cancer Hospital
Fuzhou, Fujian, China · Not yet recruiting
The first Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Not yet recruiting
Cancer Hospital Chinese Academy Of medical Sciences Shenzhen Center
Shenzhen, Guangdong, China · Not yet recruiting
Guangxi Medical University Cancer hospital & Guangxi Cancer Institute
Nanning, Guangxi, China · Not yet recruiting
Cangzhou hospital of integrated TCM-WM Hebei
Cangzhou, Hebei, China · Recruiting
Harbin Medical University Cancer Hospital-Mammary gland of internal
Haerbin, Heilongjiang, China · Not yet recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hosipital Of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Tongji Hospital Tongji Medical College of Hust
Wuhan, Hubei, China · Not yet recruiting
Hubei cancer hospital
Wuhan, Hubei, China · Not yet recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Not yet recruiting
Jiangsu province hospital
Nanjing, Jiangsu, China · Not yet recruiting
Wuxi People's Hospital
Wuxi, Jiangsu, China · Not yet recruiting
Jilin cancer hospital
Jilin City, Jilin, China · Not yet recruiting
The First Hospital Of China Medical University
Shenyang, Liaoning, China · Not yet recruiting
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China · Not yet recruiting
Shandong Cancer Hospital
Jinan, Shandong, China · Recruiting
LinYi Cancer Hospital
Linyi, Shandong, China · Not yet recruiting
The affiliated hospital of Qingdao university
Qingdao, Shandong, China · Not yet recruiting
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China · Not yet recruiting
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China · Not yet recruiting
Shanxi province cancer hospital
Taiyuan, Shanxi, China · Not yet recruiting
The First Affiliated Hospital of Xi'An Jiaotong University
Xi’an, Shanxi, China · Not yet recruiting
Sichuan province cancer hospital
Chengdu, Sichuan, China · Not yet recruiting
West China Hospital Sichuan University
Chengdu, Sichuan, China · Not yet recruiting
Tianjin Medical University Cancer Institute Hospital
Tianjin, Tianjin Municipality, China · Not yet recruiting
The First affiliated hospital Zhejiang university school of medicine
Hangzhou, Zhejiang, China · Not yet recruiting
The Second Affiliated Hospital Zhejiang School of Medicine
Hangzhou, Zhejiang, China · Not yet recruiting
Taizhou Hospital Zhejiang Province
Taizhou, Zhejiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.